Literature DB >> 1694450

IgG oligoclonal bands in sera of HIV-1 infected patients are mainly directed against HIV-1 determinants.

A Amadori1, P Gallo, R Zamarchi, M L Veronese, A De Rossi, D Wolf, L Chieco-Bianchi.   

Abstract

In a series of 60 HIV-1-infected individuals, serum electrofocusing analysis disclosed clonally restricted IgG patterns in 9 patients (15%), most with limited disease progression (stages WR1-WR3). These oligoclonal bands had a very heterogeneous light chain pattern, and most showed specificity for HIV-1 in affinity-driven transfer studies; virus specificity was more clear-cut following adsorption of sera with the relevant antigen. These findings further stress the profound B-cell function derangement in HIV-1 infection; their possible relevance to AIDS-associated lymphoma development is discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1694450     DOI: 10.1089/aid.1990.6.581

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  5 in total

1.  Additive effect of neutralizing antibody and antiviral drug treatment in preventing virus escape and persistence.

Authors:  P Seiler; B M Senn; P Klenerman; U Kalinke; H Hengartner; R M Zinkernagel
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

2.  Signature biochemical properties of broadly cross-reactive HIV-1 neutralizing antibodies in human plasma.

Authors:  Mohammad M Sajadi; George K Lewis; Michael S Seaman; Yongjun Guan; Robert R Redfield; Anthony L DeVico
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

3.  Immunoglobulin G kappa [IgG kappa] and IgG lambda paraproteinemia in a child with AIDS and response to highly active antiretroviral therapy.

Authors:  Filiz Odabasi Seeborg; Hannah Gay; Lorenz M Schmiege; David Bernard; William T Shearer
Journal:  Clin Diagn Lab Immunol       Date:  2005-11

4.  Serum adenosine deaminase and total immunoglobulin G correlate with markers of immune activation and inversely with CD4 counts in asymptomatic, treatment-naive HIV infection.

Authors:  Hayley Ipp; Annalise E Zemlin; Richard H Glashoff; Johan van Wyk; Naadira Vanker; Tim Reid; Linda-Gail Bekker
Journal:  J Clin Immunol       Date:  2012-11-16       Impact factor: 8.317

5.  B cell activation and human immunodeficiency virus infection. V. Phenotypic and functional alterations in CD5+ and CD5- B cell subsets.

Authors:  S Indraccolo; M Mion; R Zamarchi; A Veronesi; M L Veronese; M Panozzo; C Betterle; A Barelli; A Borri; A Amadori
Journal:  J Clin Immunol       Date:  1993-11       Impact factor: 8.317

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.